For example, we were unable to detect P2RX7 expression on A549 cells when using the monoclonal antibody characterized by Buell [59], whereas the use of a commercial polyclonal antibody by other authors detected its expression on various NSCLC (including A549) and SCLC cancer cell lines [22]. Here, P2RX7 is linked to cancer.